A mixed approach for proving non-inferiority in clinical trials with binary endpoints
Data(s) |
2008
|
---|---|
Resumo |
When a new treatment is compared to an established one in a randomized clinical trial, it is standard practice to statistically test for non-inferiority rather than for superiority. When the endpoint is binary, one usually compares two treatments using either an odds-ratio or a difference of proportions. In this paper, we propose a mixed approach which uses both concepts. One first defines the non-inferiority margin using an odds-ratio and one ultimately proves non-inferiority statistically using a difference of proportions. The mixed approach is shown to be more powerful than the conventional odds-ratio approach when the efficacy of the established treatment is known (with good precision) and high (e.g. with more than 56% of success). The gain of power achieved may lead in turn to a substantial reduction in the sample size needed to prove non-inferiority. The mixed approach can be generalized to ordinal endpoints. |
Identificador |
https://serval.unil.ch/?id=serval:BIB_57153ABBA5E3 isbn:1521-4036[electronic] pmid:18311852 doi:10.1002/bimj.200710410 isiid:000255262700003 |
Idioma(s) |
en |
Fonte |
Biometrical journal, vol. 50, no. 2, pp. 190-204 |
Palavras-Chave | #Anti-Bacterial Agents/therapeutic use; Clindamycin/therapeutic use; Data Interpretation, Statistical; Endpoint Determination; Female; Humans; Odds Ratio; Randomized Controlled Trials as Topic/methods; Sample Size; Therapeutic Equivalency; Vaginosis, Bacterial/drug therapy |
Tipo |
info:eu-repo/semantics/article article |